02309oam 2200457Ia 450 991069757080332120080915165423.0(CKB)5470000002389243(OCoLC)181643937(EXLCZ)99547000000238924320071120d2007 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierThe top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004[electronic resource] /Marie N. Stagnitti[Rockville, Md.] :Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality,[2007]4 unnumbered pages illustrations, tablesStatistical brief ;#186Title from title screen (viewed Sept. 15, 2008)."September 2007.""The estimates in this brief are derived from the Household Component of the 2004 Medical Expenditure Panel Survey (MEPS-HC)"--P. [1].Includes bibliographical references (page [4]).This statistical brief provides information on the top five outpatient prescription medicines ranked by total expenditures and insurance status for the Medicare population, as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2004. This brief also provides information on average total payments and average out-of-pocket payments per purchase for the top five drugs for Medicare beneficiaries, by insurance status.MedicarePharmaceutical services insuranceUnited StatesPrescription pricingUnited StatesMedicare.Pharmaceutical services insurancePrescription pricingStagnitti Marie N1386624United States.Agency for Healthcare Research and Quality.Medical Expenditure Panel Survey (U.S.)VVKVVKGPOBOOK9910697570803321The top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 20043516348UNINA03198nam 22006614a 450 991077845530332120230617041901.00-674-02041-310.4159/9780674020412(CKB)1000000000805549(OCoLC)451007081(CaPaEBR)ebrary10326097(SSID)ssj0000275530(PQKBManifestationID)12060579(PQKBTitleCode)TC0000275530(PQKBWorkID)10222836(PQKB)10256825(SSID)ssj0000488558(PQKBManifestationID)11316812(PQKBTitleCode)TC0000488558(PQKBWorkID)10458230(PQKB)11029896(MiAaPQ)EBC3300553(Au-PeEL)EBL3300553(CaPaEBR)ebr10326097(OCoLC)923111653(DE-B1597)588902(DE-B1597)9780674020412(OCoLC)1294423921(EXLCZ)99100000000080554920020719d2003 uy 0engurcn|||||||||txtccrThe X in sex[electronic resource] how the X chromosome controls our lives /David BainbridgeCambridge, Mass. Harvard University Press20031 online resource (216 p.)Bibliographic Level Mode of Issuance: Monograph0-674-01028-0 0-674-01621-1 Includes bibliographical references (p. [183]-192) and index.Frontmatter -- CONTENTS -- PROLOGUE -- 1 . MAKING A DIFFERENCE -- 2 . THE DUKE OF KENT’S TESTICLES -- 3 . THE DOUBLE LIFE OF WOMEN -- FURTHER READING -- GLOSSARY -- INDEXA tiny scrap of genetic information determines our sex; it also consigns many of us to a life of disease, directs or disrupts the everyday working of our bodies, and forces women to live as genetic chimeras. The culprit--so necessary and yet the source of such upheaval--is the X chromosome, and this is its story. An enlightening and entertaining tour of the cultural and natural history of this intriguing member of the genome, The X in Sex traces the journey toward our current understanding of the nature of X. From its chance discovery in the nineteenth century to the promise and implications of ongoing research, David Bainbridge shows how the X evolved and where it and its counterpart Y are going, how it helps assign developing human babies their sex--and maybe even their sexuality--and how it affects our lives in infinitely complex and subtle ways. X offers cures for disease, challenges our cultural, ethical, and scientific assumptions about maleness and femaleness, and has even reshaped our views of human evolution and human nature.X chromosomeSex determination, GeneticX chromosome.Sex determination, Genetic.611/.01816Bainbridge David237202MiAaPQMiAaPQMiAaPQBOOK9910778455303321The X in sex3746503UNINA